Found: 134
Select item for more details and to access through your institution.
Structure-based design of a single-chain triple-disulfide-stabilized fusion-glycoprotein trimer that elicits high-titer neutralizing responses against human metapneumovirus.
- Published in:
- PLoS Pathogens, 2023, v. 19, n. 9, p. 1, doi. 10.1371/journal.ppat.1011584
- By:
- Publication type:
- Article
An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humans.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 692, p. 1, doi. 10.1126/scitranslmed.ade4976
- By:
- Publication type:
- Article
EFFICACY AND COMPLEMENTARITY OF HIV-1 SUPPRESSION BY CD4- BINDING bNAbs.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 123
- By:
- Publication type:
- Article
PHASE 1 TRIAL OF CAP256V2LS AND VRC07-523LS ANTIBODIES AMONG WOMEN IN SOUTH AFRICA.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 395
- By:
- Publication type:
- Article
Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Elicitation of pneumovirus-specific B cell responses by a prefusion-stabilized respiratory syncytial virus F subunit vaccine.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 650, p. 1, doi. 10.1126/scitranslmed.abo5032
- By:
- Publication type:
- Article
Molecular probes of spike ectodomain and its subdomains for SARS-CoV-2 variants, Alpha through Omicron.
- Published in:
- PLoS ONE, 2022, v. 17, n. 5, p. 1, doi. 10.1371/journal.pone.0268767
- By:
- Publication type:
- Article
Stable Latent HIV Infection and Low-level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent Vorinostat.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah Vaccine.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.772864
- By:
- Publication type:
- Article
Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn Infants.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Limited Flavivirus Cross-Reactive Antibody Responses Elicited by a Zika Virus Deoxyribonucleic Acid Vaccine Candidate in Humans.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Broad Neutralization of H1 and H3 Viruses by Adjuvanted Influenza HA Stem Vaccines in Non-human Primates.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 9, p. 1, doi. 10.1371/journal.ppat.1009543
- By:
- Publication type:
- Article
Broad Neutralization of H1 and H3 Viruses by Adjuvanted Influenza HA Stem Vaccines in Non-human Primates.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
Sequence-Signature Optimization Enables Improved Identification of Human HV6-1-Derived Class Antibodies That Neutralize Diverse Influenza A Viruses.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.662909
- By:
- Publication type:
- Article
SARS-CoV-2 Viral Variants-Tackling a Moving Target.
- Published in:
- 2021
- By:
- Publication type:
- editorial
A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-21954-2
- By:
- Publication type:
- Article
Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 583, p. 1, doi. 10.1126/scitranslmed.abe5449
- By:
- Publication type:
- Article
Functional Profiling of Antibody Immune Repertoires in Convalescent Zika Virus Disease Patients.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.615102
- By:
- Publication type:
- Article
TLR7 agonist, N6-LS and PGT121 delayed viral rebound in SHIV-infected macaques after antiretroviral therapy interruption.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 2, p. 1, doi. 10.1371/journal.ppat.1009339
- By:
- Publication type:
- Article
Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics Approach.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 184, doi. 10.1002/cpt.2026
- By:
- Publication type:
- Article
Virus-Like Particle Based Vaccines Elicit Neutralizing Antibodies against the HIV-1 Fusion Peptide.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 765, doi. 10.3390/vaccines8040765
- By:
- Publication type:
- Article
A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-74949-2
- By:
- Publication type:
- Article
Monoclonal Antibodies for Prevention and Treatment of COVID-19.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen Development.
- Published in:
- Frontiers in Immunology, 2020, p. 1, doi. 10.3389/fimmu.2020.00842
- By:
- Publication type:
- Article
Characterization of a human monoclonal antibody generated from a B-cell specific for a prefusion-stabilized spike protein of Middle East respiratory syndrome coronavirus.
- Published in:
- PLoS ONE, 2020, v. 15, n. 5, p. 1, doi. 10.1371/journal.pone.0232757
- By:
- Publication type:
- Article
Longitudinal Antibody Responses in People Who Inject Drugs Infected With Similar Human Immunodeficiency Virus Strains.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials.
- Published in:
- PLoS Computational Biology, 2020, v. 16, n. 2, p. 1, doi. 10.1371/journal.pcbi.1007626
- By:
- Publication type:
- Article
Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-14579-4
- By:
- Publication type:
- Article
Glycan-dependent HIV-specific neutralizing antibodies bind to cells of uninfected individuals.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Multiple roles for HIV broadly neutralizing antibodies.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 516, p. 1, doi. 10.1126/scitranslmed.aaz2686
- By:
- Publication type:
- Article
Accurate Prediction for Antibody Resistance of Clinical HIV-1 Isolates.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-50635-w
- By:
- Publication type:
- Article
Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-10899-2
- By:
- Publication type:
- Article
A virus-like particle vaccine prevents equine encephalitis virus infection in nonhuman primates.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 492, p. N.PAG, doi. 10.1126/scitranslmed.aav3113
- By:
- Publication type:
- Article
Delayed vaginal SHIV infection in VRC01 and anti-α4β7 treated rhesus macaques.
- Published in:
- PLoS Pathogens, 2019, v. 15, n. 5, p. 1, doi. 10.1371/journal.ppat.1007776
- By:
- Publication type:
- Article
Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopes.
- Published in:
- PLoS Pathogens, 2019, v. 15, n. 4, p. 1, doi. 10.1371/journal.ppat.1007632
- By:
- Publication type:
- Article
Correction: HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Improvement of antibody functionality by structure-guided paratope engraftment.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-08658-4
- By:
- Publication type:
- Article
Lattice engineering enables definition of molecular features allowing for potent small-molecule inhibition of HIV-1 entry.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-018-07851-1
- By:
- Publication type:
- Article
Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challenge.
- Published in:
- PLoS Pathogens, 2018, v. 14, n. 12, p. 1, doi. 10.1371/journal.ppat.1007395
- By:
- Publication type:
- Article
HIV-1 Envelope Glycan Modifications that Permit Neutralization by Germline-Reverted VRC01-Class Broadly Neutralizing Antibodies.
- Published in:
- PLoS Pathogens, 2018, v. 14, n. 11, p. 1, doi. 10.1371/journal.ppat.1007431
- By:
- Publication type:
- Article
Sequencing HIV-neutralizing antibody exons and introns reveals detailed aspects of lineage maturation.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-06424-6
- By:
- Publication type:
- Article
Complete functional mapping of infection- and vaccine-elicited antibodies against the fusion peptide of HIV.
- Published in:
- PLoS Pathogens, 2018, v. 14, n. 7, p. 1, doi. 10.1371/journal.ppat.1007159
- By:
- Publication type:
- Article
Characterization of the Neutralizing Antibody Response in a Case of Genetically Linked HIV Superinfection.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Glycoengineering HIV-1 Env creates ‘supercharged’ and ‘hybrid’ glycans to increase neutralizing antibody potency, breadth and saturation.
- Published in:
- PLoS Pathogens, 2018, v. 14, n. 5, p. 1, doi. 10.1371/journal.ppat.1007024
- By:
- Publication type:
- Article
Accumulation of follicular CD8+ T cells in pathogenic SIV infection.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Exploiting glycan topography for computational design of Env glycoprotein antigenicity.
- Published in:
- PLoS Computational Biology, 2018, v. 14, n. 4, p. 1, doi. 10.1371/journal.pcbi.1006093
- By:
- Publication type:
- Article
Novel Vaccine Technologies: Essential Components of an Adequate Response to Emerging Viral Diseases.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Characterization of broadly neutralizing antibody responses to HIV-1 in a cohort of long term non-progressors.
- Published in:
- PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0193773
- By:
- Publication type:
- Article